Pharmabiz11h
Praxis Precision Medicines to showcase updates from pipeline of epilepsy programmes at American Epilepsy Society Annual Meeting 2024
Praxis Precision Medicines, Inc, a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by ...
Pharmabiz16h
Symbiosis Pharmaceutical expands business development team in US
Symbiosis Pharmaceutical expands business development team in US: Stirling, UK Saturday, November 30, 2024, 18:00 Hrs [IST] Symbiosis Pharmaceutical Services, a world-class contra ...
Pharmabiz18h
Hutchmed announces continued inclusion of Orpathys in the National Reimbursement Drug List in China at current terms
Hutchmed announces continued inclusion of Orpathys in the National Reimbursement Drug List in China at current terms: Hong Kong, Shanghai Saturday, November 30, 2024, 16:00 Hrs [I ...
Pharmabiz19h
Boehringer Ingelheim introduces Eurican L4 vaccine to protect dogs against leptospirosis
Boehringer Ingelheim, a global leader in animal health, has begun its launch of Eurican L4, delivering an important new ...
Pharmabiz20h
NIHR launches £25 million funding to decarbonise the health and social care system
NIHR launches £25 million funding to decarbonise the health and social care system: United Kingdom Saturday, November 30, 2024, 14:00 Hrs [IST] The NIHR has launched a new £25 m ...
Pharmabiz21h
Zai Lab announces the inclusion of Augtyro for ROS1+ NSCLC and other updates in China’s National Reimbursement Drug List
Zai Lab announces the inclusion of Augtyro for ROS1+ NSCLC and other updates in China’s National Reimbursement Drug List: Shanghai Saturday, November 30, 2024, 13:00 Hrs [IST] Z ...
Pharmabiz21h
Entod Pharmaceuticals outperforms market growth in ENT sector
Entod Pharmaceuticals outperforms market growth in ENT sector: Our Bureau, Mumbai Saturday, November 30, 2024, 12:45 Hrs [IST] Entod Pharmaceuticals, a leader in the eye care sect ...
Pharmabiz21h
Quadria Capital Report reveals USD 3 billion annual investment opportunity in climate-health adaptation for India
Quadria Capital Report reveals USD 3 billion annual investment opportunity in climate-health adaptation for India: Our Bureau, Mumbai Saturday, November 30, 2024, 12:20 Hrs [IST] ...
Pharmabiz22h
Kane Biotech announces change in US distribution partner for revyve antimicrobial wound gel
Kane Biotech announces change in US distribution partner for revyve antimicrobial wound gel: Winnipeg, Manitoba Saturday, November 30, 2024, 12:00 Hrs [IST] Kane Biotech Inc. anno ...
Pharmabiz23h
Bayer further expands global incubator network with Bayer Co.Lab Berlin
Bayer further expands global incubator network with Bayer Co.Lab Berlin: Berlin Saturday, November 30, 2024, 11:00 Hrs [IST] Bayer announced the inauguration of its new life scien ...
Pharmabiz1d
Qiagen introduces novel tools for customizing digital PCR assays and NGS panels for microbial analysis
Venlo, the Netherlands Saturday, November 30, 2024, 10:00 Hrs [IST] ...
Pharmabiz1d
DGTR reviews PUC/PCN methodology for acrylonitrile butadiene rubber investigation
DGTR reviews PUC/PCN methodology for acrylonitrile butadiene rubber investigation: Shardul Nautiyal, Mumbai Saturday, November 30, 2024, 08:00 Hrs [IST] In order to define the sco ...